467 related articles for article (PubMed ID: 2150581)
41. Clinical evaluation of a new triphasic oral contraceptive: norgestimate and ethinyl estradiol.
Gauthier A; Upmalis D; Dain MP
Acta Obstet Gynecol Scand Suppl; 1992; 156():27-32. PubMed ID: 1324554
[TBL] [Abstract][Full Text] [Related]
42. Cycle control with triphasic norgestimate and ethinyl estradiol, a new oral contraceptive agent.
Andolsek KM
Acta Obstet Gynecol Scand Suppl; 1992; 156():22-6. PubMed ID: 1324553
[TBL] [Abstract][Full Text] [Related]
43. [Clinical observations using the new contraceptive preparation containing gestagen].
Marianowski L; Cyganek A; Grzechocińska B
Wiad Lek; 1994 Oct; 47(19-20):747-9. PubMed ID: 7483621
[TBL] [Abstract][Full Text] [Related]
44. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
Norris LA; Bonnar J
Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
[TBL] [Abstract][Full Text] [Related]
45. A multicenter clinical evaluation of a new monophasic combination: Minulet (gestodene and ethinyl estradiol).
de Andrade RP
Int J Fertil; 1989 Sep; 34 Suppl():22-30. PubMed ID: 2576253
[TBL] [Abstract][Full Text] [Related]
46. A new ultra-low-dose combination oral contraceptive.
Woutersz TB
J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
[TBL] [Abstract][Full Text] [Related]
47. Ultrasound evaluation of ovarian activity under oral contraceptives.
Hoogland HJ; Skouby SO
Contraception; 1993 Jun; 47(6):583-90. PubMed ID: 8334892
[TBL] [Abstract][Full Text] [Related]
48. Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel.
Fioretti P; Fruzzetti F; Navalesi R; Ricci C; Miccoli R; Cerri M; Orlandi MC; Melis GB
Contraception; 1987 Mar; 35(3):229-43. PubMed ID: 2956055
[TBL] [Abstract][Full Text] [Related]
49. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
Kamal I; Hefnawi F; Younis N
Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of the new antiandrogenic oral contraceptive Belara.
Zahradnik HP; Goldberg J; Andreas JO
Contraception; 1998 Feb; 57(2):103-9. PubMed ID: 9589837
[TBL] [Abstract][Full Text] [Related]
51. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
Godsland IF; Crook D; Devenport M; Wynn V
Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
[TBL] [Abstract][Full Text] [Related]
52. A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives.
Dunson TR; McLaurin VL; Aguayo EL; de Silva P; Calventi V; Gerais AS; Serani RG
Contraception; 1993 Jun; 47(6):515-25. PubMed ID: 8334888
[TBL] [Abstract][Full Text] [Related]
53. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
Petersen KR; Sidelmann J; Skouby SO; Jespersen J
Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344
[TBL] [Abstract][Full Text] [Related]
54. [Clinical study of a low-dose contraceptive--Femodene].
Rachev E; Damianov L; Dukovski A; Katsarova M
Akush Ginekol (Sofiia); 1995; 34(3):71-3. PubMed ID: 8787249
[TBL] [Abstract][Full Text] [Related]
55. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ
J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821
[TBL] [Abstract][Full Text] [Related]
56. Changes in androgens during treatment with four low-dose contraceptives.
Coenen CM; Thomas CM; Borm GF; Hollanders JM; Rolland R
Contraception; 1996 Mar; 53(3):171-6. PubMed ID: 8689882
[TBL] [Abstract][Full Text] [Related]
57. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
Rossmanith WG; Steffens D; Schramm G
Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
[TBL] [Abstract][Full Text] [Related]
58. Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris.
Mango D; Ricci S; Manna P; Miggiano GA; Serra GB
Contraception; 1996 Mar; 53(3):163-70. PubMed ID: 8689881
[TBL] [Abstract][Full Text] [Related]
59. Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination.
Cullberg G; Samsioe G; Andersen RF; Bredesgaard P; Andersen NB; Ernerot H; Fanøe E; Fylling P; Haack-Sørensen PE; Klottrup P; Pedersen JH; Sandager T
Contraception; 1982 Sep; 26(3):229-43. PubMed ID: 6217028
[TBL] [Abstract][Full Text] [Related]
60. Clinical evaluation of a new oral contraceptive, 'Pregnon'.
van de Walle J; Weijers MJ
Curr Med Res Opin; 1975; 3(3):151-6. PubMed ID: 1149483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]